Latest Asx News

Nagambie Resources has uncovered compelling historical and recent data on antimony and gold veins at its Whroo Project, setting the stage for a targeted drilling campaign that could unlock significant value.

Golden Horse Minerals has reported compelling soil geochemistry results at its Southern Cross Project, revealing multiple significant gold anomalies and securing a strategic mining lease to bolster exploration efforts.

VIP Gloves Limited has obtained a short-term interest-free loan of approximately AUD$1 million ahead of a planned share placement, as it faces potential delisting from the ASX pending a critical reinstatement decision.

Trek Metals reports a significant high-grade manganese discovery at the Pearana Prospect in Western Australia's Pilbara region, with assays peaking at 57% Mn and advancing towards drill-ready status.

Barton Gold has confirmed significant depth extensions at its Tunkillia Project's 223 Deposit, with new drilling intersecting broad mineralisation below the previously modelled pit floor. This discovery supports an expanded resource estimate and ongoing optimisation studies.

Patronus Resources has initiated an on-market takeover offer for Matsa Resources at $0.045 per share, representing a significant premium and aiming to consolidate its position in gold exploration.

Euroz Hartleys, acting for Patronus Resources, has launched an unconditional on-market takeover bid for Matsa Resources at A$0.045 per share, aiming to acquire all shares not already controlled. The offer period runs from February 24 to March 24, 2025.

Firetail Resources has identified several significant electromagnetic conductor targets at its Skyline Copper Project in Newfoundland, marking a major step forward in exploration with promising geological signatures for copper-zinc mineralisation.

PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.

Radiopharm Theranostics' RAD 101 radiotracer demonstrates high sensitivity in detecting brain metastases using a novel PET-mpMRI approach, with a Phase 2b trial now recruiting in the US.

Coolabah Metals Limited is undertaking a $3-4 million capital raise to fund the acquisition of Broken Hill Mines Pty Ltd and its subsidiary, aiming to re-list on the ASX and focus on developing the Rasp and Pinnacles Mines.

Incitec Pivot Limited confirms its FY25 outlook remains steady despite operational hurdles at Phosphate Hill and a CFO transition, while progressing key strategic separations.